Discounted Cash Flow (DCF) Analysis Levered
OPKO Health, Inc. (OPK)
$1.3
+0.04 (+3.17%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 990.27 | 901.93 | 1,435.41 | 1,774.72 | 1,004.20 | 1,080.64 | 1,162.90 | 1,251.43 | 1,346.69 | 1,449.21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -109.14 | -172.52 | 39.48 | 38.34 | -95.19 | -75.04 | -80.75 | -86.89 | -93.51 | -100.63 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -27.86 | -12.74 | -33.68 | -32.16 | -24.58 | -23.41 | -25.19 | -27.11 | -29.17 | -31.39 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -137 | -185.26 | 5.79 | 6.18 | -119.77 | -98.45 | -105.94 | -114 | -122.68 | -132.02 |
Weighted Average Cost Of Capital
| Share price | $ 1.3 |
|---|---|
| Beta | 1.646 |
| Diluted Shares Outstanding | 719.06 |
| Cost of Debt | |
| Tax Rate | 16.22 |
| After-tax Cost of Debt | 3.22% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 11.148 |
| Total Debt | 313.92 |
| Total Equity | 934.78 |
| Total Capital | 1,248.70 |
| Debt Weighting | 25.14 |
| Equity Weighting | 74.86 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 990.27 | 901.93 | 1,435.41 | 1,774.72 | 1,004.20 | 1,080.64 | 1,162.90 | 1,251.43 | 1,346.69 | 1,449.21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -109.14 | -172.52 | 39.48 | 38.34 | -95.19 | -75.04 | -80.75 | -86.89 | -93.51 | -100.63 |
| Capital Expenditure | -27.86 | -12.74 | -33.68 | -32.16 | -24.58 | -23.41 | -25.19 | -27.11 | -29.17 | -31.39 |
| Free Cash Flow | -137 | -185.26 | 5.79 | 6.18 | -119.77 | -98.45 | -105.94 | -114 | -122.68 | -132.02 |
| WACC | ||||||||||
| PV LFCF | -75.71 | -74.64 | -73.59 | -72.55 | -71.53 | |||||
| SUM PV LFCF | -438.44 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 9.15 |
| Free cash flow (t + 1) | -134.66 |
| Terminal Value | -1,883.40 |
| Present Value of Terminal Value | -1,215.69 |
Intrinsic Value
| Enterprise Value | -1,654.13 |
|---|---|
| Net Debt | 160.73 |
| Equity Value | -1,814.86 |
| Shares Outstanding | 719.06 |
| Equity Value Per Share | -2.52 |